ClinicalTrials.gg
Drug

Remdesivir clinical trials

Also written Veklury and GS-5734.

studies test it
48
open now
10
in phase 3
24
first study started
2016

How each study uses remdesivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the remdesivir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Oct 2020 · VEKLURY · NDA 214787 (FDA, Drugs@FDA)
European Union
3 Jul 2020 · Veklury · EMEA/H/C/005622 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Remdesivir
39
Remdesivir (RDV)
3
RDV
2

Brand

Veklury
17

Development codes

GS-5734
12
PRD8099279
1

Studies by the year they started

48 studies that test it; most in 2020 (28)

Studies that test remdesivir, by start year
YearStudies
20162
20181
202028
20218
20221
20231
20241
20255
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
19
Phase 3
24
Phase 4
6
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 39

Gilead Sciences (6) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Capital Medical University (2) · QuantumLeap Healthcare Collaborative (1) · University of Melbourne (1) · Lisa Barrett (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · University of Derby (1)

Often tested with

Tested in the same studies.

Hydroxychloroquine (8) · Lopinavir-ritonavir drug combination (5) · Tocilizumab (4) · Interferon beta-1a (4) · Nirmatrelvir (3) · Ritonavir (3) · Ivermectin (3) · Nirmatrelvir and ritonavir drug combination (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test remdesivir, phase 3 first.

Studies

Open first, then newest update. How each study uses remdesivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test remdesivir →

Given beside what is tested · 25 — remdesivir is usual care or a partner of the new treatment

Showing 20 of 25.

As the comparator · 3 — what is tested is compared with remdesivir

Codes

What other systems call remdesivir · ClinicalTrials.gg INT000432

  • MeSH (NLM) C000606551remdesivirConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3QKI37EEHEREMDESIVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 2284718Confirmed FDA, Wikidata
  • Wikidata Q28209496remdesivirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152185RemdesivirOne source FDA
  • DrugBank DB14761One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.